Buchumschlag

Survival with chronic myeloid leukaemia after failing milestones

Therapy after failing response milestones in CML is controversial. Risks associated with comorbidities, drug toxicities or transplantation may preclude switching to another tyrosine kinase inhibitor (TKI) or other treatments. No information on long-term survival of failing patients is available. To...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lauseker, Michael (VerfasserIn) , Hehlmann, Rüdiger (VerfasserIn) , Hochhaus, Andreas (VerfasserIn) , Saußele, Susanne (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 September 2023
In: Leukemia
Year: 2023, Jahrgang: 37, Heft: 11, Pages: 2231-2236
ISSN:1476-5551
DOI:10.1038/s41375-023-02028-2
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-023-02028-2
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41375-023-02028-2
Volltext
Verfasserangaben:Michael Lauseker, Rüdiger Hehlmann, Andreas Hochhaus and Susanne Saußele

MARC

LEADER 00000caa a2200000 c 4500
001 186857847X
003 DE-627
005 20240307044029.0
007 cr uuu---uuuuu
008 231027s2023 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41375-023-02028-2  |2 doi 
035 |a (DE-627)186857847X 
035 |a (DE-599)KXP186857847X 
035 |a (OCoLC)1425209986 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lauseker, Michael  |d 1981-  |e VerfasserIn  |0 (DE-588)1058710265  |0 (DE-627)79743223X  |0 (DE-576)414848438  |4 aut 
245 1 0 |a Survival with chronic myeloid leukaemia after failing milestones  |c Michael Lauseker, Rüdiger Hehlmann, Andreas Hochhaus and Susanne Saußele 
264 1 |c 19 September 2023 
300 |b Illustrationen 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.10.2023 
520 |a Therapy after failing response milestones in CML is controversial. Risks associated with comorbidities, drug toxicities or transplantation may preclude switching to another tyrosine kinase inhibitor (TKI) or other treatments. No information on long-term survival of failing patients is available. To systematically analyse survival after reaching, or not reaching, response milestones, 1342 patients from CML-study IV with newly diagnosed CML in chronic phase and regular molecular tests were studied. Landmark survival analyses were done by <0.1%, 0.1-1%, >1-10% and >10% BCR::ABL1IS at 3, 6, 12 and 24 months up to 14 years. 10- to 12-year survival of patients who failed the failure milestones (>10% BCR::ABL1IS at 6 months, >1% BCR::ABL1IS at 12 months) ranged around 80%, 10% less than in responding patients. These results suggest revision of milestones. Age (more or less than 60 years) had no major impact on survival differences, but on hazard ratios and CML-specific survival. Switching to alternative therapies, which was observed in 26.9% of the patients, did not change the main results. The data show that TKI-treated patients not reaching failure milestones still may derive benefit from continuing TKI-treatment and provide a basis for individualised decisions, if failing patients are confronted with risks of alternative treatments. 
650 4 |a Chronic myeloid leukaemia 
650 4 |a Molecularly targeted therapy 
700 1 |a Hehlmann, Rüdiger  |d 1941-  |e VerfasserIn  |0 (DE-588)1037003489  |0 (DE-627)751737879  |0 (DE-576)390939463  |4 aut 
700 1 |a Hochhaus, Andreas  |d 1959-  |e VerfasserIn  |0 (DE-588)1107039339  |0 (DE-627)863321976  |0 (DE-576)474976130  |4 aut 
700 1 |a Saußele, Susanne  |d 1968-  |e VerfasserIn  |0 (DE-588)115839860  |0 (DE-627)69162786X  |0 (DE-576)29010694X  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 37(2023), 11, Seite 2231-2236  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Survival with chronic myeloid leukaemia after failing milestones 
773 1 8 |g volume:37  |g year:2023  |g number:11  |g pages:2231-2236  |g extent:6  |a Survival with chronic myeloid leukaemia after failing milestones 
856 4 0 |u https://doi.org/10.1038/s41375-023-02028-2  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41375-023-02028-2  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20231027 
993 |a Article 
994 |a 2023 
998 |g 115839860  |a Saußele, Susanne  |m 115839860:Saußele, Susanne  |d 60000  |d 61200  |e 60000PS115839860  |e 61200PS115839860  |k 0/60000/  |k 1/60000/61200/  |p 4  |y j 
998 |g 1037003489  |a Hehlmann, Rüdiger  |m 1037003489:Hehlmann, Rüdiger  |d 60000  |e 60000PH1037003489  |k 0/60000/  |p 2 
999 |a KXP-PPN186857847X  |e 4399219777 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"note":["Gesehen am 15.03.04"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia"}],"language":["eng"],"id":{"zdb":["2008023-2"],"eki":["32046699X"],"issn":["1476-5551"]},"origin":[{"dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group"}],"pubHistory":["Nachgewiesen 11.1997 -"],"disp":"Survival with chronic myeloid leukaemia after failing milestonesLeukemia","part":{"pages":"2231-2236","volume":"37","year":"2023","extent":"6","issue":"11","text":"37(2023), 11, Seite 2231-2236"},"recId":"32046699X","type":{"bibl":"periodical","media":"Online-Ressource"}}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Michael","family":"Lauseker","display":"Lauseker, Michael","role":"aut"},{"given":"Rüdiger","display":"Hehlmann, Rüdiger","family":"Hehlmann","role":"aut"},{"role":"aut","display":"Hochhaus, Andreas","family":"Hochhaus","given":"Andreas"},{"given":"Susanne","family":"Saußele","display":"Saußele, Susanne","role":"aut"}],"recId":"186857847X","id":{"eki":["186857847X"],"doi":["10.1038/s41375-023-02028-2"]},"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"19 September 2023"}],"name":{"displayForm":["Michael Lauseker, Rüdiger Hehlmann, Andreas Hochhaus and Susanne Saußele"]},"note":["Gesehen am 27.10.2023"],"title":[{"title":"Survival with chronic myeloid leukaemia after failing milestones","title_sort":"Survival with chronic myeloid leukaemia after failing milestones"}],"language":["eng"],"physDesc":[{"extent":"6 S.","noteIll":"Illustrationen"}]} 
SRT |a LAUSEKERMISURVIVALWI1920 

Ähnliche Einträge